RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genomma Lab Internacional SAB de CV Stock

Genomma Lab Internacional SAB de CV ROCE 2024

Genomma Lab Internacional SAB de CV ROCE

0.35

Ticker

LABB.MX

ISIN

MX01LA010006

WKN

A0Q4TC

In 2024, Genomma Lab Internacional SAB de CV's return on capital employed (ROCE) was 0.35, a 8% increase from the 0.32 ROCE in the previous year.

Genomma Lab Internacional SAB de CV Aktienanalyse

What does Genomma Lab Internacional SAB de CV do?

Genomma Lab Internacional SAB de CV is a leading Mexican company that specializes in the manufacturing and marketing of branded products in the health, beauty, and hygiene sector. The company was founded in 1996 by Rodrigo Herrera as a family business that initially focused on the sale of hemorrhoid creams. Over the years, however, the company has evolved into a global market leader and now distributes a wide range of products in more than 20 countries worldwide. Genomma Lab's business model is based on the development, production, and marketing of its own branded products, which are sold through a broad and diverse network of distribution channels, including drugstores, supermarkets, pharmacies, and online shops. Genomma Lab has three main business segments: Consumer Health, Personal Care, and Pharmaceuticals. The Consumer Health segment includes products such as creams, ointments, tablets, and capsules for the treatment of conditions such as fungal infections, itching, pain, and inflammation. Some of the most well-known brands in this segment are Tío Nacho, Cicatricure, Asepxia, and Siluet 40. Personal Care offers a wide range of beauty products, including hair care products, skin care products, deodorants, and dental care products. Some of the most notable brands in this segment are Goicoechea, Genomma Lab Originals, and Tugaboos. Pharmaceuticals is Genomma Lab's third business segment and includes prescription medications that are prescribed by doctors to treat a variety of conditions. However, this segment is still relatively small and accounts for only a small portion of the overall business. Every year, Genomma Lab introduces numerous new products to the market and continually works to expand and improve its product lines. The company has a strong focus on innovation and invests continuously in research and development to develop new and more effective products and optimize the effectiveness of its existing products. Genomma Lab has also made a name for itself by designing innovative marketing strategies and promoting its products through aggressive advertising campaigns and sales promotion initiatives. In fact, the company has conducted some of the most well-known advertising campaigns in the Mexican television landscape, and its products are often promoted by well-known personalities and celebrities. In summary, Genomma Lab is a leading company in the health, beauty, and hygiene sector, specializing in the manufacturing and marketing of branded products. The company has a broad and diverse network of distribution channels and utilizes aggressive marketing strategies to promote and sell its products. The company has experienced impressive growth in recent years and is expected to continue growing and expanding in the future. Genomma Lab Internacional SAB de CV ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Genomma Lab Internacional SAB de CV's Return on Capital Employed (ROCE)

Genomma Lab Internacional SAB de CV's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Genomma Lab Internacional SAB de CV's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Genomma Lab Internacional SAB de CV's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Genomma Lab Internacional SAB de CV’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Genomma Lab Internacional SAB de CV stock

What is the ROCE (Return on Capital Employed) of Genomma Lab Internacional SAB de CV this year?

The ROCE of Genomma Lab Internacional SAB de CV is 0.35 undefined this year.

How has the ROCE (Return on Capital Employed) of Genomma Lab Internacional SAB de CV developed compared to the previous year?

The ROCE of Genomma Lab Internacional SAB de CV has increased by 8% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Genomma Lab Internacional SAB de CV?

A high Return on Capital Employed (ROCE) indicates that Genomma Lab Internacional SAB de CV has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Genomma Lab Internacional SAB de CV?

A low ROCE (Return on Capital Employed) can indicate that Genomma Lab Internacional SAB de CV has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Genomma Lab Internacional SAB de CV impact the company?

An increase in the ROCE of Genomma Lab Internacional SAB de CV can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Genomma Lab Internacional SAB de CV affect the company?

A decrease in ROCE of Genomma Lab Internacional SAB de CV can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Genomma Lab Internacional SAB de CV?

Some factors that can affect Genomma Lab Internacional SAB de CV's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Genomma Lab Internacional SAB de CV so important for investors?

The ROCE of Genomma Lab Internacional SAB de CV is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Genomma Lab Internacional SAB de CV take to improve the ROCE?

To improve the ROCE, Genomma Lab Internacional SAB de CV can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Genomma Lab Internacional SAB de CV pay?

Over the past 12 months, Genomma Lab Internacional SAB de CV paid a dividend of 0.59 MXN . This corresponds to a dividend yield of about 2.29 %. For the coming 12 months, Genomma Lab Internacional SAB de CV is expected to pay a dividend of 0.63 MXN.

What is the dividend yield of Genomma Lab Internacional SAB de CV?

The current dividend yield of Genomma Lab Internacional SAB de CV is 2.29 %.

When does Genomma Lab Internacional SAB de CV pay dividends?

Genomma Lab Internacional SAB de CV pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Genomma Lab Internacional SAB de CV?

Genomma Lab Internacional SAB de CV paid dividends every year for the past 7 years.

What is the dividend of Genomma Lab Internacional SAB de CV?

For the upcoming 12 months, dividends amounting to 0.63 MXN are expected. This corresponds to a dividend yield of 2.46 %.

In which sector is Genomma Lab Internacional SAB de CV located?

Genomma Lab Internacional SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genomma Lab Internacional SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genomma Lab Internacional SAB de CV from 9/17/2024 amounting to 0.2 MXN, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Genomma Lab Internacional SAB de CV pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Genomma Lab Internacional SAB de CV in the year 2023?

In the year 2023, Genomma Lab Internacional SAB de CV distributed 0.763 MXN as dividends.

In which currency does Genomma Lab Internacional SAB de CV pay out the dividend?

The dividends of Genomma Lab Internacional SAB de CV are distributed in MXN.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genomma Lab Internacional SAB de CV

Our stock analysis for Genomma Lab Internacional SAB de CV Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomma Lab Internacional SAB de CV Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.